OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Neurology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	67
Management of neuropsychiatric symptoms in dementia	58
Update on management of cerebral venous thrombosis	56
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	55
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	52
The recent surge of functional movement disorders: social distress or greater awareness?	51
The role of the gut microbiome in Alzheimer's disease pathophysiology	42
Historical development and contemporary use of neuromodulation in human spinal cord injury	40
Hereditary motor neuropathies	40
From basic mechanisms to therapeutic perspectives in cluster headache	39
Gene therapies for CMT neuropathies: from the bench to the clinic	36
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	36
Central nervous system adverse events of immune checkpoint inhibitors	35
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	34
Editorial: Epilepsy advances in 2023	28
Neurology education in the era of artificial intelligence	28
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	28
Microglia in multiple sclerosis – pathogenesis and imaging	28
Connecting tremors – a circuits perspective	27
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	24
Editorial introductions	24
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	24
New developments in myotonic dystrophies from a multisystemic perspective	23
Multiple sclerosis in china: the current state of diagnosis and management	23
Development of neural repair therapy for chronic spinal cord trauma: soluble nogo receptor decoy from discovery to clinical trial	22

Updates in neuro-otology	21
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	20
Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples	20
Editorial: Update on movement disorders	20
Editorial: Modern Gestalt approach to neuromuscular disorders: time for a precision Gestalt	20
Thymectomy in myasthenia gravis	19
Clinical impact of molecular profiling in rare brain tumors	19
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	19
The FSHD jigsaw: are we placing the tiles in the right position?	18
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	18
Unveiling the neuroimaging-genetic intersections in the human brain	18
Burning vertex syndrome: a novel unclassified headache- its preliminary observations, and possible mechanisms	17
Threat of resurgence or hope for global eradication of poliovirus?	17
Editorial: Advances in neuro-oncology: stepping in the right direction	17
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	17
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	17
Levodopa infusion therapies for Parkinson disease	17
Migraine in women: a review	17
Idiopathic intracranial hypertension: expanding our understanding	17
Red flags in multiple sclerosis	16
Gauging and controlling excitability in cortical disorders	16
MRI for the diagnosis of limb girdle muscular dystrophies	16
Update on dermatomyositis	16
fMRI-based spatio-temporal parcellations of the human brain	16
Electrical stimulation of the peripheral and central vestibular system	15
Obesity-related neuropathy: the new epidemic	15
Acute stroke care in low and middle-income countries	14
Parkinson's disease – genetic cause	14
Editorial: The gap between academic advances and therapy development in motor neuron disease	14
Diet and migraine: what is proven?	14
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	14
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	13
New developments in diagnostics and treatment of adult-onset focal dystonia	13
The state of art on the use of patient reported outcomes in migraine	13
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	13
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	13
Recent advances in Alzheimer disease genetics	13
Optic neuritis: current challenges in diagnosis and management	13
Neuroinflammation and immunometabolism in neurodegenerative diseases	13
Novel approaches to treatment of leptomeningeal metastases	13
Neuromuscular junction disorders beyond myasthenia gravis	13
Progress in spinal muscular atrophy research	13
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	13
Targeting IDH1/IDH2 mutations in gliomas	13
Visually induced dizziness	13
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	12
Update on genetics of amyotrophic lateral sclerosis	12
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	12
Monitoring multiple sclerosis: digital and fluid phase biomarkers	12
Advanced neuroimaging techniques in epilepsy	12

Abnormal energy metabolism in ALS: a key player?	12
Fluid phase biomarkers in multiple sclerosis	12
Recent insights in striated muscle laminopathies	12
Long COVID and especially headache syndromes	11
Diagnosing viral encephalitis and emerging concepts	11
Update on modifiable risk factors for Alzheimer's disease and related dementias	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
Current gaps in acute reperfusion therapies	11
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	11
Editorial: Making the invisible visible: updates on vestibular neurology	11
Current trend in air pollution exposure and stroke	11
Pharmacotherapy of cerebellar and vestibular disorders	11
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	11
Imaging cortical lesions in multiple sclerosis	11
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	11
Editorial: Seizure disorders: 2023 update	11
Muscle ultrasound in myopathies	10
Peripheral visual field loss and activities of daily living	10
Nonneurologic causes of binocular diplopia for the neurologist	10
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	10
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	10
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	10
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	10
Motion sickness: current concepts and management	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum	9
Perception and control of a virtual body in immersive virtual reality for rehabilitation	9
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	9
Editorial: Cerebrovascular disease	9
Progression in multiple sclerosis – a long-term problem	9
Progress in treatment of gliomas	9